Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
Noosa News22 hours agoComing Soon: Wilderluxe Lake Keepit Is the Luxe Countryside Escape That Combines Curated Adventure and Inspired Stargazing
-
Noosa News21 hours agoGout Gout breaks 10 seconds for 100m with illegal tailwind at Australian Athletics Championships
-
General24 hours agoPM, Deputy PM at odds over NZ response to US tariffs
-
Noosa News23 hours agoWoman gives birth to stranger’s baby after receiving wrong embryo at Monash IVF